What is GH Research PLC (GHRS) stock price today?

GH Research PLC (GHRS) currently trades at $20.53 per share. The stock has a market capitalization of $1.26B and a P/E ratio of —x.

Is GHRS stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, GH Research PLC has a Smart Value Score of 26/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 1/9 and Altman Z-Score is 10.59.

Is GH Research PLC financially healthy?

GH Research PLC's Piotroski F-Score is 1/9 (weak financial health). The Altman Z-Score of 10.59 places it in the safe zone.

GHRS

GH Research PLC

NASDAQ: GHRS · HEALTHCARE · BIOTECHNOLOGY

$20.53

+7.15% today

Updated 2026-04-30

Market cap

$1.26B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.79

Dividend yield

—

52W range

$9 – $25

Volume

0.2M

Market cap

$1.26B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.79

Dividend yield

—

52W range

$9 – $25

Volume

0.2M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

8.0

Quality

3.0

Profitability

5.0

Valuation

C+

1/9

Piotroski F-Score

Weak

10.6

Altman Z-Score

Safe zone

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$39.25

+91.18%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

3 Strong Buy6 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Altman Z 10.59 — safe zone

+ Debt/equity 0.00x — low leverage

Risks

- Piotroski 1/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-12.27M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-22.46M	$-35.59M	$-38.96M	$-48.26M	$-14.14M
EPS	—	—	—	—	$-0.79
Free cash flow	$-26.27M	$-33.44M	$-42.33M	$-43.67M	$-12.27M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
GHRS	$1.26B	26	4.3	3.0	5.0	8.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

GH Research PLC trades at $20.53. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of 10.59, it sits in the safe zone.

Frequently asked questions

What is GH Research PLC's stock price?

GH Research PLC (GHRS) trades at $20.53.

Is GH Research PLC overvalued?

Smart Value Score 26/100 (Grade F, Strong Sell).

What is the price target of GH Research PLC (GHRS)?

The analyst target price is $39.25, representing +91.2% upside from the current price of $20.53.

Piotroski F-Score?

1/9 — weak financial health.

Altman Z-Score?

10.59 — safe zone.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.ghres.com

Quick metrics

P/S ratio—

ROE-21.00%

Beta1.00

50D MA$15.72

200D MA$14.54

Shares out0.06B

Float0.02B

Short ratio—

Avg volume0.2M

Performance

1 week+11.31%

1 month+9.30%

3 months+3.16%

YTD+28.66%

1 year—

3 years—

5 years—

Compare

GHRS vs LLY →GHRS vs JNJ →GHRS vs ABBV →Stock screener →